Expanding the
Global Supply of Critical Medical Isotopes
Reactor enabled and Cyclotron enabled production through a coordinated TRTR/TRIGA network mechanism delivering reliable material for diagnostic imaging, radiotherapeutics, and emerging isotopes.
Supply is critical.
Dependability is everything.
The expansion of medical radioisotope production benefits nearly every part of the medical and scientific ecosystem—from patients receiving life-saving treatments to governments strengthening national healthcare resilience.
Demand for nuclear medicine is accelerating while traditional production capacity faces aging infrastructure. Cancer care and emerging radiopharmaceuticals require dependable, scalable access.
"Building a distributed diverse production platform to ensure continuum of isotope supply."
Avoiding Single Points of Failure
We integrate university and national laboratory TRTR/TRIGA reactors and cyclotrons into a unified framework for a diverse array of customers.
Radiopharmacies
CDMOs
Pharma & Biotech
Academic Centers
Government Partners
Infrastructure + Access + Execution
Unlike single-facility producers, our model is built on coordinated national assets and long-term institutional partnerships. Providing:
The result → predictable supply at scale.
From Regional Production to Global Impact
Our network approach enables resilient domestic supply while supporting international clinical development and commercial distribution.
Network Legend
PARTNER WITH US
Let’s secure isotope availability for the next generation of nuclear medicines.